GlobeNewswire Inc.··Researchandmarkets.ComBristol Myers' Abecma Poised for Explosive Growth as CAR-T Therapy Expands Beyond Relapsed Myeloma
Abecma CAR-T therapy market surging on rising myeloma cases and regulatory wins. BMS-backed treatment faces headwinds from tariffs but eyes earlier-line expansion.
BMYCELGrregulatory approvalmultiple myeloma